Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Jim Cramer: There Are Too Many Software as a Service Companies

Video Credit: The Street - Duration: 01:01s - Published < > Embed
Jim Cramer: There Are Too Many Software as a Service Companies

Jim Cramer: There Are Too Many Software as a Service Companies

Jim Cramer has a warning for investors.

He believes that there needs to be consolidation in both the cybersecurity and Software as a Service (SaaS) sectors.

"Salesforce last quarter was very good.

By the way, the ServiceNow quarter wasn't bad...Splunk had a very good quarter.

Workday said some things that were negative, and that really accelerated the downturn.

I think that this group is one that trades together like in 2000, but it's much better.

And those had no earnings and many of them were corrupt.

These are all good companies.

You need to see Okta bottom.

You need to see CrowdStrike bottom, you need to see ZScaler bottom.

You need to see the cybersecurity stocks, in general, bottom.

There's too many of those.

There's too many software as a service companies.

You need to see a bit of a shakeout, maybe some mergers, and then you can get a bottom.

But in 2000, the bottom took a long time," said Jim Cramer.

Watch the full clip above.

Bull Market Fantasy: LIVE TUESDAY & THURSDAY @10:45AM Subscribe to our Youtube Channel for more videos : Listen our latest Podcasts on Soundcloud Catch Up: Today's Top News Videos Below

0
shares
ShareTweetSavePostSend
 

You Might Like


Tweets about this


Recent related videos from verified sources

Jim Cramer's Top Stock Pick to Buy for the 5G Revolution [Video]Jim Cramer's Top Stock Pick to Buy for the 5G Revolution

The 5G telecom revolution is on the way, and there are numerous tech company's jockeying to provide the hardware to fuel the shift. Skyworks and Qorvo will be big players in providing the tech for..

Credit: The Street     Duration: 03:02Published

Novartis Still a Buy Despite Controversy Over Blockbuster Drug, Jim Cramer Says [Video]Novartis Still a Buy Despite Controversy Over Blockbuster Drug, Jim Cramer Says

Novartis and its CEO may have gotten a black eye amid a dust-up over tainted research, but the pharma giant is still a buy, according to Jim Cramer during his exclusive video-conference call on..

Credit: The Street     Duration: 02:30Published

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.